Complete Wegovy vs Mounjaro Dose Comparison Guide
Wegovy vs Mounjaro: Complete Dose Range Availability
When comparing Wegovy vs Mounjaro, having access to every single dose throughout your treatment journey is crucial for successful weight management. EverydayMeds stocks all five Wegovy doses (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg) alongside the complete Mounjaro range, ensuring seamless progression without pharmacy switches. This comprehensive approach means you start your Wegovy vs Mounjaro treatment knowing your entire escalation pathway is secure. The complete dose availability eliminates common treatment interruptions that occur when pharmacies run out of specific strengths during the critical escalation phases.
Both medications require mandatory dose escalation over 16-20 weeks, making consistent supply essential for treatment success. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, whilst our Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99 for your first 12 weeks. When evaluating Wegovy vs Mounjaro, this complete dose security ensures you can focus on your weight management goals rather than supply concerns. The ability to plan your entire treatment journey with one trusted pharmacy eliminates the stress of finding new suppliers mid-treatment.
Wegovy vs Mounjaro Pricing: Investment in Your Complete Journey
Understanding the full cost implications when comparing Wegovy vs Mounjaro requires examining the entire dose progression, not just starter prices. Wegovy begins at £79.99 for 0.25mg (weeks 1-4) with code FIRST40, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to maintenance at £209.99 (2.4mg). Our Getting Started bundles offer convenience rather than just savings—the Intro Duo (0.25mg & 0.5mg) costs £169.99 for your first 8 weeks. Returning customers benefit from code DOSE25, whilst new customers use FIRST40 at checkout to reach these final prices.
Long-term treatment planning reveals the true value when considering Wegovy vs Mounjaro options. The 2.4mg maintenance dose represents your ongoing investment once you reach therapeutic levels around week 17. Our Consistency bundles (same dose ×2) provide supply security: Consistency 2.4mg costs £419.99 for two months of maintenance treatment. This transparent pricing structure, combined with our complete dose availability, means no surprise costs or supply gaps during your Wegovy vs Mounjaro treatment journey.
Clinical Evidence: Wegovy vs Mounjaro Mechanisms
When examining Wegovy vs Mounjaro from a clinical perspective, the fundamental difference lies in their receptor mechanisms. Wegovy (semaglutide) acts as a GLP-1 receptor agonist, whilst Mounjaro (tirzepatide) functions as a dual GIP/GLP-1 receptor agonist. In the STEP trials, patients taking Wegovy alongside diet and exercise experienced approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021).
Both treatments require clinical assessment and prescription, but the Wegovy vs Mounjaro choice often depends on individual response and tolerability. The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events with Wegovy (HR 0.80). Your prescriber can help determine which mechanism may be most suitable based on your medical history and weight management goals during your clinical assessment.
How Wegovy Works in Your Weight Management Journey
Wegovy functions as a GLP-1 receptor agonist, mimicking your body's natural incretin hormones that regulate appetite and food intake. The medication works on brain appetite centres, particularly in the hypothalamus, to reduce hunger signals and promote satiety after smaller meals. This mechanism may help reduce food cravings and the psychological drive to eat, making it easier to adhere to a reduced-calorie diet. The once-weekly injection provides consistent appetite regulation throughout the week, unlike daily medications that may have fluctuating effects. When combined with increased physical activity, this hormonal approach supports sustainable weight management rather than relying solely on willpower or restrictive eating patterns.
Complete Ordering Process: From Assessment to Maintenance
Beginning your Wegovy vs Mounjaro journey starts with our comprehensive 3-minute online clinical assessment, designed to evaluate your suitability for prescription-only weight management medication. Our qualified prescribers review your submission within 3 working days (or 24 hours with express service), considering your BMI, medical history, and current medications. Once approved, your chosen dose ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. Our GPhC-registered pharmacy (#9012878) ensures every order meets UK regulatory standards for prescription-only medicines. This streamlined process continues throughout your entire dose escalation, with automatic reminders and easy reordering to maintain consistent treatment.
Storage and Practical Considerations: Wegovy vs Mounjaro
Storage requirements present a key practical difference when comparing Wegovy vs Mounjaro for lifestyle compatibility. Wegovy FlexTouch pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy more suitable for frequent travellers or those with unpredictable schedules. Both require refrigeration at 2-8°C before first use, but Wegovy's superior temperature tolerance provides greater flexibility. The mandatory dose escalation for both treatments means planning ahead for holidays or business travel, where the storage difference becomes particularly relevant. Each pen contains 4 doses, requiring careful planning to avoid running out mid-cycle during travel.
Complete Treatment Journey: Wegovy vs Mounjaro Long-term Planning
Understanding the full treatment trajectory is essential when choosing between Wegovy vs Mounjaro, particularly regarding dose escalation timelines and maintenance requirements. Wegovy's 16-week escalation (0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg) follows a structured monthly progression that cannot be accelerated. Having every dose readily available eliminates the common problem of treatment interruption due to supply shortages during critical escalation phases.
The maintenance phase begins around week 17 with 2.4mg weekly injections, representing your long-term commitment to weight management. Our Ultimate Stability Trio provides three months of 2.4mg supply, ensuring consistency during this crucial maintenance period. When comparing Wegovy vs Mounjaro for long-term treatment, the ability to maintain consistent supply through one pharmacy becomes invaluable for treatment adherence and success.
Why Complete Dose Availability Matters for Wegovy vs Mounjaro Success
Treatment interruptions during dose escalation can significantly impact the effectiveness of both Wegovy and Mounjaro, making complete dose availability crucial for optimal outcomes. Missing scheduled dose increases may require restarting the escalation process, extending your time to reach therapeutic levels and potentially affecting your weight management progress. Our comprehensive stock ensures seamless progression through every dose level, maintaining the precise escalation schedule that clinical trials have proven most effective. The psychological benefit of knowing your complete treatment pathway is secure allows you to focus entirely on dietary changes and increased physical activity rather than supply concerns.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
